Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ridderström M[au]:

An ultrafast system for signaling mechanical pain in human skin. Nagi SS et al. Sci Adv. (2019)

An evolutionary approach to the design of glutathione-linked enzymes. Mannervik B et al. Chem Biol Interact. (1998)

Brilliant blue G treatment facilitates regeneration after optic nerve injury in the adult rat. Ridderström M et al. Neuroreport. (2014)

Search results

Items: 32

1.

An ultrafast system for signaling mechanical pain in human skin.

Nagi SS, Marshall AG, Makdani A, Jarocka E, Liljencrantz J, Ridderström M, Shaikh S, O'Neill F, Saade D, Donkervoort S, Foley AR, Minde J, Trulsson M, Cole J, Bönnemann CG, Chesler AT, Bushnell MC, McGlone F, Olausson H.

Sci Adv. 2019 Jul 3;5(7):eaaw1297. doi: 10.1126/sciadv.aaw1297. eCollection 2019 Jul.

2.

Brilliant blue G treatment facilitates regeneration after optic nerve injury in the adult rat.

Ridderström M, Ohlsson M.

Neuroreport. 2014 Dec 3;25(17):1405-10. doi: 10.1097/WNR.0000000000000286.

PMID:
25340564
3.

CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolites.

Ahlström MM, Ridderström M, Zamora I.

J Med Chem. 2007 Nov 1;50(22):5382-91. Epub 2007 Oct 4.

PMID:
17915853
4.

CYP2C9 structure-metabolism relationships: optimizing the metabolic stability of COX-2 inhibitors.

Ahlström MM, Ridderström M, Zamora I, Luthman K.

J Med Chem. 2007 Sep 6;50(18):4444-52. Epub 2007 Aug 14.

PMID:
17696334
5.

Virtual screening and scaffold hopping based on GRID molecular interaction fields.

Ahlström MM, Ridderström M, Luthman K, Zamora I.

J Chem Inf Model. 2005 Sep-Oct;45(5):1313-23.

PMID:
16180908
6.

Combining pharmacophore and protein modeling to predict CYP450 inhibitors and substrates.

Masimirembwa CM, Ridderström M, Zamora I, Andersson TB.

Methods Enzymol. 2002;357:133-44. No abstract available.

PMID:
12424905
8.

Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.

Li XQ, Björkman A, Andersson TB, Ridderström M, Masimirembwa CM.

J Pharmacol Exp Ther. 2002 Feb;300(2):399-407.

PMID:
11805197
9.

Analysis of selective regions in the active sites of human cytochromes P450, 2C8, 2C9, 2C18, and 2C19 homology models using GRID/CPCA.

Ridderström M, Zamora I, Fjellström O, Andersson TB.

J Med Chem. 2001 Nov 22;44(24):4072-81.

PMID:
11708911
10.

Competitive CYP2C9 inhibitors: enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis.

Afzelius L, Zamora I, Ridderström M, Andersson TB, Karlén A, Masimirembwa CM.

Mol Pharmacol. 2001 Apr;59(4):909-19.

PMID:
11259637
11.

The active-site residue tyr-175 in human glyoxalase II contributes to binding of glutathione derivatives.

Ridderström M, Jemth P, Cameron AD, Mannervik B.

Biochim Biophys Acta. 2000 Sep 29;1481(2):344-8.

PMID:
11018726
12.

Arginines 97 and 108 in CYP2C9 are important determinants of the catalytic function.

Ridderström M, Masimirembwa C, Trump-Kallmeyer S, Ahlefelt M, Otter C, Andersson TB.

Biochem Biophys Res Commun. 2000 Apr 21;270(3):983-7.

PMID:
10772937
13.
14.

Reaction mechanism of glyoxalase I explored by an X-ray crystallographic analysis of the human enzyme in complex with a transition state analogue.

Cameron AD, Ridderström M, Olin B, Kavarana MJ, Creighton DJ, Mannervik B.

Biochemistry. 1999 Oct 12;38(41):13480-90.

PMID:
10521255
15.

Crystal structure of human glyoxalase II and its complex with a glutathione thiolester substrate analogue.

Cameron AD, Ridderström M, Olin B, Mannervik B.

Structure. 1999 Sep 15;7(9):1067-78.

16.

Unfolding and refolding of human glyoxalase II and its single-tryptophan mutants.

Dragani B, Cocco R, Ridderström M, Stenberg G, Mannervik B, Aceto A.

J Mol Biol. 1999 Aug 13;291(2):481-90.

PMID:
10438633
17.

Human glutathione transferase A4-4 crystal structures and mutagenesis reveal the basis of high catalytic efficiency with toxic lipid peroxidation products.

Bruns CM, Hubatsch I, Ridderström M, Mannervik B, Tainer JA.

J Mol Biol. 1999 May 7;288(3):427-39.

PMID:
10329152
18.

Involvement of an active-site Zn2+ ligand in the catalytic mechanism of human glyoxalase I.

Ridderström M, Cameron AD, Jones TA, Mannervik B.

J Biol Chem. 1998 Aug 21;273(34):21623-8.

19.

An evolutionary approach to the design of glutathione-linked enzymes.

Mannervik B, Cameron AD, Fernandez E, Gustafsson A, Hansson LO, Jemth P, Jiang F, Jones TA, Larsson AK, Nilsson LO, Olin B, Pettersson PL, Ridderström M, Stenberg G, Widersten M.

Chem Biol Interact. 1998 Apr 24;111-112:15-21. Review.

PMID:
9679539
21.

Mutagenesis of residue 157 in the active site of human glyoxalase I.

Ridderström M, Cameron AD, Jones TA, Mannervik B.

Biochem J. 1997 Nov 15;328 ( Pt 1):231-5.

22.

Crystal structure of human glyoxalase I--evidence for gene duplication and 3D domain swapping.

Cameron AD, Olin B, Ridderström M, Mannervik B, Jones TA.

EMBO J. 1997 Jun 16;16(12):3386-95.

23.
25.

Optimized heterologous expression of the human zinc enzyme glyoxalase I.

Ridderström M, Mannervik B.

Biochem J. 1996 Mar 1;314 ( Pt 2):463-7.

26.

Molecular cloning, heterologous expression, and characterization of human glyoxalase II.

Ridderström M, Saccucci F, Hellman U, Bergman T, Principato G, Mannervik B.

J Biol Chem. 1996 Jan 5;271(1):319-23.

27.

Similar toxic effect of 1,3-bis(2-chloroethyl)-1-nitrosourea on lymphocytes from human subjects differing in the expression of glutathione transferase M1-1.

Jungnelius U, Ridderström M, Hansson J, Ringborg U, Mannervik B.

Biochem Pharmacol. 1994 May 18;47(10):1777-80.

PMID:
8204094
29.

Catalytic and molecular properties of glyoxalase I.

Mannervik B, Ridderström M.

Biochem Soc Trans. 1993 May;21(2):515-7. Review. No abstract available.

PMID:
8359522
30.

Mapping of glutathione transferase (GST) genes in the rat.

Klinga-Levan K, Andersson A, Hanson C, Ridderström M, Stenberg G, Mannervik B, Vajdy M, Szpirer J, Szpirer C, Levan G.

Hereditas. 1993;119(3):285-96.

32.

Glutathione-linked enzymes in normal and tumor cells and their role in resistance against genotoxic agents.

Mannervik B, Berhane K, Castro VM, Olin B, Ridderström M, Vignani R, Kozarich JW, Ringborg U.

Princess Takamatsu Symp. 1990;21:253-62. Review.

PMID:
2134680

Supplemental Content

Loading ...
Support Center